APA (7th ed.) Citation

M, L., M, S., AK, S., I, V., C, D. N., N, S., & LK, R. (2016). Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development. Cytometry. Part B, Clinical cytometry, 90(2), 117. https://doi.org/10.1002/cyto.b.21259

Chicago Style (17th ed.) Citation

M, Liang, Schwickart M, Schneider AK, Vainshtein I, Del Nagro C, Standifer N, and Roskos LK. "Receptor Occupancy Assessment by Flow Cytometry as a Pharmacodynamic Biomarker in Biopharmaceutical Development." Cytometry. Part B, Clinical Cytometry 90, no. 2 (2016): 117. https://doi.org/10.1002/cyto.b.21259.

MLA (9th ed.) Citation

M, Liang, et al. "Receptor Occupancy Assessment by Flow Cytometry as a Pharmacodynamic Biomarker in Biopharmaceutical Development." Cytometry. Part B, Clinical Cytometry, vol. 90, no. 2, 2016, p. 117, https://doi.org/10.1002/cyto.b.21259.